BRIDGEWATER, N.J., Jan. 27, 2022 /PRNewswire/ -- Insmed
Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases, today announced that it will release its fourth quarter
and full year 2021 financial results on Thursday, February 17, 2022.
Insmed management will provide a business and pipeline update in
addition to a discussion of the financial results in a conference
call for investors from 8:00 to 9:30 a.m.
ET on Thursday, February 17, 2022.
Shareholders and other interested parties may participate in the
conference call by dialing (844) 200-6205 (U.S. toll free), (646)
904-5544 (U.S. local), or +1-929-526-1599 (international) and
referencing access code 359415. The call will also be webcast live
on the company's website at www.insmed.com.
A replay of the conference call will be accessible approximately
1 hour after its completion through March
17, 2022, by dialing (866) 813-9403 (U.S. toll free), (929)
458-6194 (U.S. local), or +44-204-525-0658 (international) and
referencing access code 838814. A webcast of the call will also be
archived for 90 days under the Investor Relations section of the
company's website at www.insmed.com.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States, Europe, and
Japan to treat a chronic,
debilitating lung disease. The Company is also progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing
footprint across Europe and in
Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-fourth-quarter-and-full-year-2021-financial-results-conference-call-and-provide-a-business-and-pipeline-update-on-thursday-february-17-2022-301468908.html
SOURCE Insmed Incorporated